- Home
- RWT vs CTMX Comparison
RWT vs CTMX Comparison
Compare RWT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RWT | CTMX |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 743.6M | 596.2M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | RWT | CTMX |
|---|---|---|
| Price | $5.95 | $5.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $7.04 | ★ $8.86 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $138,103,000.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | ★ N/A | $22.58 |
| Revenue Growth | N/A | ★ 36.45 |
| 52 Week Low | $4.68 | $0.40 |
| 52 Week High | $6.97 | $6.35 |
Technical Indicators
Market Signals| Indicator | RWT | CTMX |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 46.26 |
| Support Level | $5.91 | $3.83 |
| Resistance Level | $6.18 | $6.20 |
| Average True Range (ATR) | 0.21 | 0.33 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 27.67 | 28.11 |
Price Performance
Historical ComparisonAbout RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.